Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Endoscopic Treatment of Non-variceal Upper GI-bleeding With High Risk of Recurrency - OTSC (Over-the-scope-clip) Versus Standard Therapy (STING2)

NCT03331224 is registered in ClinicalTrials.gov with Kliniken Ludwigsburg-Bietigheim gGmbH as lead sponsor.

NCT NCT03331224
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03331224 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Endoscopic Treatment of Non-variceal Upper GI-bleeding With High Risk of Recurrency - OTSC (Over-the-scope-clip) Versus Standard Therapy (STING2)
Lead sponsor
Kliniken Ludwigsburg-Bietigheim gGmbH
Phase
Not applicable
Overall status
Unknown status
Start date
September 1, 2017
Completion date
September 1, 2019
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute upper gastrointestinal hemorrhage